Correction to: A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature

Affiliations

• ¹ Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. Von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
• ² Faculty of Medicine, Department of Medical Biology, Erciyes University, 38030, Kayseri, Turkey.
• ³ Molecular Biology and Genetics Department, Gevher Nesibe Genome and Stem Cell Institute, Betul-Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey.
• ⁴ Intergen, Ankara, Turkey.
• ⁵ Faculty of Medicine, Department of Pediatrics, Division of Pediatric Hematology & Oncology, Erciyes University, Kayseri, Turkey.
• ⁶ T Cell Signalling Laboratory, Sir William Dunn School of Pathology, Oxford University, Oxford, OX2 3RE, UK.
• ⁷ Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, INSERM UMR1163, Paris, France.
• ⁸ Faculty of Health Sciences, Hasan Kalyoncu University, Medical Point Hospital, Gaziantep, Turkey.
• ⁹ Faculty of Medicine, Department of Medical Biology, Erciyes University, 38030, Kayseri, Turkey. ahmet.eken@gmail.com.
• ¹⁰ Molecular Biology and Genetics Department, Gevher Nesibe Genome and Stem Cell Institute, Betul-Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University, Kayseri, Turkey. ahmet.eken@gmail.com.
• ¹¹ Division of Pediatric Immunology and Rheumatology, Department of Pediatrics, Dr. Von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. fabian.hauck@med.uni-muenchen.de.
• ¹² Munich Centre for Rare Diseases (M-ZSELMU), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. fabian.hauck@med.uni-muenchen.de.